The effects of BR-DIM (BioResponse 3, 3’-Diindolylmethane) administered pre-prostatectomy on the androgen receptor (AR).
Elisabeth I. Heath(The Barbara Ann Karmanos Cancer Institute), Fazlul H. Sarkar(Wayne State University), Michael L. Cher(The Barbara Ann Karmanos Cancer Institute), Dhananjay Chitale(Henry Ford Hospital), Clara Hwang(Henry Ford Health System), Jing Li(Wayne State University), Nilesh Gupta(Henry Ford Health System), Susan Bolton(The Barbara Ann Karmanos Cancer Institute), Daryn Smith(The Barbara Ann Karmanos Cancer Institute), Mani Menon(Henry Ford Hospital), Seema Sethi(Janssen (United States)), Isaac J. Powell(Wayne State University), Lance K. Heilbrun(Wayne State University)
Cited by 0
Related Papers
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells
|PLoS ONE|2010|406
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
|Clinical Cancer Research|2013|358